Please do not leave this page until complete. This can take a few moments.
The state’s buzziest industry slowed down this year, although some sectors will do better than others next year.
Hopkinton’s Isto Biologics completed a merger with a California biologics company known for innovation in October.
Worcester Polytechnic Institute has launched a new MBA program in analytics. The coursework aims to equip students with analytics tools specifically for science, technology, engineering, and math, and will begin in the fall 2024 semester.
Worcester Polytechnic Institute will soon offer a master’s degree in artificial intelligence.
Waters Corp., a Milford-based manufacturer of scientific equipment, has opened a new global capacity center in Bengaluru, India, one of the company’s rapidly growing markets.
Chicago-based biotech giant AbbVie, which has a large bioresearch facility in Worcester, will acquire Waltham’s ImmunoGen and its flagship ovarian cancer treatment drug in an more than $10-billion transaction.
Marlborough-based ReWalk Robotics, a firm that develops assistive walking devices, has added artificial intelligence capabilities to its next prototype.
Psychemedics, an Acton-based manufacturer of drug testing kits, has hired Daniella Mehalik as the company’s vice president of finance.
Marlborough medical device and technology firm Boston Scientific has completed its acquisition of a Minnesota-based medical company and its chronic low back pain treatment technology.
The Massachusetts Senate and President Karen Spilka joined a growing exodus Tuesday from X
Multinational tech company Intel has sold the former site of its Hudson manufacturing facility for $12 million to a company specializing in real estate redevelopment.
The City of Marlborough has filed a lawsuit against CapGemini America for unpaid property taxes related to its former offices at 45 Bartlett St.
Natick weight loss company Allurion Technologies reported a 40% sequential revenue growth in the third quarter, the first quarter in which the company has been publicly traded on the New York Stock Exchange, despite stock price declining in the
Marlborough biopharma firm Phio Pharmaceuticals has enrolled its first patient in a clinical trial, entering the next phase of its strategic plan to move into the clinical development space.
Ares Communications Group of Marlborough has announced the launch of a media platform that the company says will provide content-based marketing.
Framingham-based Alira Health has partnered with FORWARD, a national database for rheumatic diseases, to create an enhanced patient registry for autoimmune disease Lupus.